View Full List of Delegate Testimonials | Round Table DiscussionsSee Who is Attending Tri-Con
Spanning five days this year, the event now includes more activities including: 2 partnering forums, 5 symposia, 18 short courses, and 12 core programs.
Join over 3,000 attendees in interactive lectures, discussions, and various receptions as a way to facilitate networking opportunities and hearing differing views and perspectives on poignant issues facing you and our industry today.
Core Programs
February 21-23
Molecular DiagnosticsPersonalized DiagnosticsCancer Molecular Markers
Circulating Tumor CellsNEW - Genomic Screening and Diagnosis
Mastering Medicinal Chemistry SummitTranslational Science
Oncology Clinical TrialsNEW - De-Risking Drug Discovery
Integrated R&D Informatics & Knowledge Management
NEW - Bioinformatics & Cancer Informatics
Cancer Molecular MarkersCirculating Tumor CellsBioinformatics & Cancer Informatics
Oncology Clinical TrialsCancer Biologics
Organized by:Cambridge Healthtech Institute Your Life Science Network
NEW - Symposia
February 19-20
Targeting Cancer Stem Cells in OncologyCloud ComputingPhage and Yeast Display of Difficult TargetsPoint-of-Care DiagnosticsNext Generation Pathology
Emerging Targeted OncologyEarly Stage Molecular Diagnostics
Short Courses
February 20
SC1 Identification, Characterization and Targeting of Cancer Stem Cells
SC2 Roadmap for Accelerating Commercialization of Molecular Diagnostics
SC3 Understanding EMT: Mechanisms and Metastasis to Met
SC4 Network Pharmacology
SC5 Next-Generation Sequencing in the Cloud Era
SC7 Latest Advances in Molecular Pathology, Part I (Basic)
SC8 Best Practices in Translational Informatics
SC9 Pharmacology and Drug Discovery in the Allosteric World
SC10 Digital PCR Applications and Advances
SC11 CTCs From Bench to Bed: Streamlining from Research to Clinical Practice
SC12 First-in-Human Study and Risk Mitigation Strategy for Biologics
SC13 Scientists: Business Training 101
SC14 Adaptive Oncology Clinical Trials
SC15 Latest Advances in Molecular Pathology, Part II (Advanced)
SC16 Ontologies for the Bio-Science Industry: Development and Use
SC17 Mastering Physicochemical Properties-Based Analysis to Deliver Improved Drug Candidates
SC18 Regulatory Approval of a Therapeutic & Companion Diagnostic: Nuts & Bolts
2012 Brochure
Premier Sponsors
Past Short CourseDVDs Available:
